腫瘍細胞と血小板の結合:カテープシンB型タンパク質酶によって誘発され,プロスタサイクリンによって抑制される
まとめ
腫瘍細胞は,宿主血小板の塊化を引き起こして広がる可能性があります. システインタンパク質酶を阻害し,プロスタサイクリンを使用すると,腫瘍細胞誘発の血小板凝集が低下し,キャセプシンB活性と転移の間の関連性が示唆されています.
科学分野:
- 腫瘍学 腫瘍学
- バイオケミストリー バイオケミストリー
- 血液学 ヘマトロジ
背景:
- 腫瘍細胞の転移は複雑なプロセスです.
- 血小板の集積は,転移のカスケードに関与している.
- 腫瘍誘発の血小板凝集における特定の酵素の役割については,さらなる解明が必要である.
研究 の 目的:
- 腫瘍細胞誘発の血小板集積とシステインタンパク質酶活性との関係を調査する.
- 腫瘍細胞によって誘発される血小板凝集に対するシステインプロテインアース阻害剤とプロスタサイクリンの効果を決定する.
主な方法:
- B16アメラノティックメラノーマ細胞を用いて,インビトロで血小板の集積を誘発した.
- システインプロテインアース阻害剤が血小板の集積とキャセプシンBの活性の両方に与える影響を評価した.
- 腫瘍細胞およびパパイン誘発の血小板凝集に対するプロスタサイクリンの抑制効果を調べた.
主要な成果:
- システインタンパク質酶の阻害剤は,B16アメラノティックメラノーマ誘発の血小板凝集とキャセプシンBの活性に並行して減少することを示しました.
- プロスタサイクリンは,腫瘍細胞とパパイン (カテープシンB模倣剤) によって誘発される血小板の集積を効果的に抑制しました.
結論:
- システインタンパク質酵素,特にキャセプシンBは,腫瘍細胞が誘発する血小板凝集を促進する上で重要な役割を果たす可能性があります.
- システインプロテインアースの活性をターゲットにしたり,プロスタサイクリンのような薬物を利用したりすることは,潜在的な抗転移的戦略を表す可能性があります.
さらに関連する動画
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
関連する概念動画
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Activation of Integrins
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
